Implementation of newborn screening for SCID (Severe Combined Immunodeficiency), a major accomplishment for Immunodeficiency Canada.
“This is a monumental triumph to children born with severe combined immunodeficiency (SCID) and their families. Newborn screening will detect this problem early before complications develop, and allow for prompt life-saving interventions such as bone marrow transplantation. Usually the diagnosis of SCID is either missed or delayed until the age of 6-12 months of age, after patients suffer from severe and recurrent infections, and sometimes irreversible damage to organs such as the lungs. Newborn screening for SCID will no doubt save many lives and prevent suffering of children.”
Professor Chaim Roifman, MD, FRCPC
Chair and Scientific Director, Immunodeficiency Canada
“We are proud of our initiative to bring newborn screening for SCID to Ontario and look forward to working with the other provinces and territories to make it nation wide.”
Richard Thompson, CFRE
Chief Executive Officer